Organ-specific metastatic landscape dissects PD-(L)1 blockade efficacy in advanced non-small cell lung cancer: applicability from clinical trials to real-world practice

Abstract Background Organ-specific metastatic context has not been incorporated into the clinical practice of guiding programmed death-(ligand) 1 [PD-(L)1] blockade, due to a lack of understanding of its predictive versus prognostic value. We aim at delineating and then incorporating both the predic...

תיאור מלא

שמור ב:
מידע ביבליוגרפי
Main Authors: Si-Cong Ma, Xue Bai, Xue-Jun Guo, Li Liu, Lu-Shan Xiao, Yan Lin, Jia-Le Tan, Xiao-Ting Cai, Yu-Xiang Wen, Hu Ma, Q. John Fu, Meng-Xin Leng, Yan-Pei Zhang, Li-Li Long, Ze-Qin Guo, De-Hua Wu, Jian-Guo Zhou, Zhong-Yi Dong
פורמט: Artigo
שפה:Inglês
יצא לאור: BMC 2022-04-01
סדרה:BMC Medicine
נושאים:
Metastatic-organ landscape
Non-small cell lung cancer
Immune checkpoint inhibitor
Programmed death-(ligand) 1
גישה מקוונת:https://doi.org/10.1186/s12916-022-02315-2
תגים: הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
טוען...

פריטים דומים